Effectiveness and Safety of Medical Abortion with Mifepristone and Sublingual Misoprostol up to 63 Days of Gestation
Background: The use of medical abortion increases among unplanned pregnant women. The primary objective of this study is to assess the outcomes of using a combination of Mifepristone followed by sublingual Misoprostol for the termination of pregnancy up to 63 gestational days. The...
Saved in:
| Main Authors: | Prakasit Saengbanyang, Thanyarat Wongwananuruk, Nalinee Panichyawat, Natchara Sukapatrittikul Powell, Nichamon Parkpinyo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2024-09-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/51/10/10.31083/j.ceog5110218 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A randomized comparison of three early medical abortion regimes: Mifepristone and misoprostol, misoprostol alone and methotrexate and misoprostol
by: Renuka Brijwal, et al.
Published: (2025-07-01) -
Acceptability of misoprostol-only medication abortion dispensed by mail-order or retail pharmacy: a qualitative study based on in-depth interviews in the United States
by: Dana M. Johnson, et al.
Published: (2025-12-01) -
Efficacy of a four-drug combined regimen compared to uterine curettage in the treatment of incomplete medical abortion: a prospective observational study
by: Yanlin Feng, et al.
Published: (2025-04-01) -
Effectiveness and acceptability of home use of misoprostol for medical abortion up to 10 weeks of pregnancy
by: Volodymyr Podolskyi, et al.
Published: (2023-05-01) -
Medicamentous abortion with mifepristone and misoprostol in Serbia and Montenegro
by: Stojnić Jelena, et al.
Published: (2006-01-01)